nitroblue tetrazolium has been researched along with moxalactam in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dabrowska, M; Gabryelewicz, A; Prokopowicz, J; Wołosowicz, N; Wysocka, J | 1 |
1 trial(s) available for nitroblue tetrazolium and moxalactam
| Article | Year |
|---|---|
Does ceftazidime or latamoxef affect the phagocytic capabilities of human granulocytes?
Topics: Bacterial Infections; Blood Bactericidal Activity; Ceftazidime; Clinical Trials as Topic; Female; Granulocytes; Humans; Male; Middle Aged; Moxalactam; Nitroblue Tetrazolium; Phagocytosis; Random Allocation | 1987 |